Characterizing Differences in CAR-T cell Therapy Outcomes Based on Sex in Patients with Large B-cell Lymphoma

Key Points

• CAR-T cell therapy outcomes differ significantly by sex, with variations noted in treatment responses.
• Female patients demonstrated higher treatment efficacy, with a response rate observed at 75%.
• Analysis of clinical records from lymphoma patients focused on assessing treatment outcomes by sex.
• Understanding these differences may lead to personalized therapy strategies for better patient outcomes.